Show simple item record

AuthorCrouse J.J.
AuthorMoustafa A.A.
AuthorBogaty S.E.R.
AuthorHickie I.B.
AuthorHermens D.F.
Available date2019-11-03T11:47:37Z
Publication Date2018
Publication NameSchizophrenia Research
ResourceScopus
ISSN9209964
URIhttp://dx.doi.org/10.1016/j.schres.2018.06.060
URIhttp://hdl.handle.net/10576/12207
AbstractCognitive impairment is argued to represent a core feature of psychosis-spectrum illnesses. However, within-diagnosis heterogeneity is common, and risk factors for poor cognition remain to be examined after statistically accounting for heterogeneity. Accordingly, we used a data-driven technique (cluster analysis) to empirically-derive cognitive clusters across diagnoses and examined whether concurrent substance use or a history of a neurodevelopmental/behavioral disorder differed between clusters. Data from 135 young help-seekers (aged 12–30 years) with a psychosis-spectrum illness were retrospectively analyzed. Ward's hierarchical cluster analysis classified three cognitive clusters characterized by: (1) normal-range; (2) mixed; and (3) grossly-impaired performance. Despite mostly comparable clinical and demographic measures, cluster 1 had superior socio-occupational functioning and the highest estimated premorbid IQ, followed sequentially by clusters 2 and 3. Proportions of cannabis and amphetamine users did not differ significantly across clusters, nor did rates of patients with a neurodevelopmental/behavioral disorder history. Cluster 3 was however comprised of fewer ‘risky’ drinkers, possibly reflecting reduced opportunity for social drinking associated with cognitive impairment. Estimated premorbid IQ predicted cluster membership (2 vs. 1 & 3 vs. 1), as did clinician-rated socio-occupational functioning and ‘not being enrolled in school or tertiary education’ (3 vs. 1). Our results suggest that concurrent substance use and history of a neurodevelopmental/behavioral disorder do not adequately explain cluster-level cognitive variance in this sample. Future work should integrate neurobiological measures associated with cognition (e.g. white matter integrity) to discern whether clusters reflect neurobiological subtypes better representative of pathophysiology than present symptom-based classifications.
SponsorThis work was supported by a Research Training Program stipend through the University of Sydney awarded to J.J.C. and a National Health and Medical Research Council Australia Fellowship (no. 511921 ) awarded to I.B.H. These funders had no role in the design and conduct of the study; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.
Languageen
PublisherElsevier B.V.
SubjectCluster analysis
Neurocognition
Psychosis-spectrum
Psychosocial functioning
Substance use
TitleParcellating cognitive heterogeneity in early psychosis-spectrum illnesses: A cluster analysis
TypeArticle
Pagination91 - 98
Volume Number202


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record